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1 Abstract 14 
Rheumatoid arthritis (RA) is a debilitating and painful inflammatory autoimmune disease 15 
characterised by the accumulation of leukocytes in the synovium, cartilage destruction and bone 16 
erosion. The immunomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) 17 
has been widely studied and the recent observations that syndecan-3 (SDC3) is selectively pro-18 
inflammatory in the joint led us to hypothesise that SDC3 might play an important role in MSC 19 
biology. MSCs isolated from bone marrow of wild type and Sdc3-/- mice were used to assess 20 
immunophenotype, differentiation, adhesion and migration properties and cell signalling pathways. 21 
While both cell types show similar differentiation potential and forward scatter values, the cell 22 
complexity in wild type MSCs was significantly higher than in Sdc3-/- cells and was accompanied by 23 
lower spread surface area. Moreover, Sdc3-/- MSCs adhered more rapidly to collagen type I and 24 
showed a dramatic increase in AKT phosphorylation, accompanied by a decrease in ERK1/2 25 
phosphorylation compared with control cells. In a mouse model of antigen-induced inflammatory 26 
arthritis, intraarticular injection of Sdc3-/- MSCs yielded enhanced recovery compared to injection of 27 
wild type MSCs. In conclusion, our data suggest that syndecan-3 regulates MSC adhesion and 28 
efficacy in inflammatory arthritis, likely via induction of the AKT pathway. 29 
2 Introduction 30 
Syndecans are transmembrane heparan sulphate proteoglycans (HSPG) that consist of a core 31 
protein with heparan sulphate glycosaminoglycan chains covalently attached to the ectodomain. 32 
They form part of the glycocalyx, which comprises a network of membrane-bound proteoglycans 33 
and glycoproteins on the surface of many different cell types1.  There are four mammalian 34 
syndecans, designated syndecan-1 (SDC1), -2, -3, and -4, which have protein cores with 35 
characteristic structural domains2. The variable ectodomain, which is exposed to the extracellular 36 
environment, contains two or more heparan sulphate chains and in some cases also chondroitin 37 
sulphate chains. Through their ectodomain syndecans interact with a variety of extracellular and 38 
membrane proteins thus modulation many signalling pathways and biological processes including 39 
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adhesion, proliferation, differentiation and inflammation3,4. The hydrophobic transmembrane domain 40 
is followed by a short intracellular domain containing two domains highly conserved across all 41 
syndecans and a small highly variable domain which is unique across all four syndecans. The 42 
syndecan intracellular domain binds to cytoskeletal proteins, scaffold proteins and intracellular 43 
kinases involved in signal transduction and gene expression regulation, thus transducing signals 44 
collected by the extra cellular domain to both the cytoplasm and the nucleus5,6. 45 
Syndecan-3 (SDC3) has the largest core protein of all four mammalian syndecans and can harbour 46 
both heparan sulphate and chondroitin sulphate chains7. SDC3 is expressed in several cell types 47 
and is involved in the regulation of growth factor signalling8,9,  Notch and BMP signalling10,11, 48 
adhesion and migration12,13,  proliferation10,14 and differentiation10,15. 49 
Inflammation is a central feature of rheumatoid arthritis that affects around 1% of the population and 50 
can result in disability and morbidity. Chemokines are involved in stimulating the infiltration of 51 
leukocytes into inflamed tissue and the expression of a CXCL8 binding site on endothelial SDC3 in 52 
human RA suggests a role for this HSPG in inflammatory disease16. We demonstrated that SDC3 53 
plays a dual role in inflammation depending on the tissue and vascular bed. In the joint it is pro-54 
inflammatory, since its deletion leads to reduced leukocyte recruitment and the severity of arthritis. 55 
However, in the skin and cremaster SDC3 plays an anti-inflammatory role, since its deletion leads to 56 
enhanced leukocyte interaction with the endothelium and recruitment17.  Furthermore, an article 57 
recently published by Eustace et al. characterises the role of soluble SDC3 in inflammation using in 58 
vitro and in vivo models18. The authors show that soluble SDC3 binds chemokines, reduces 59 
leukocyte migration in vitro and ameliorates disease severity in mouse models of arthritis. The 60 
observed anti-inflammatory mechanisms of shed SDC3 appear to be associated with competitive 61 
binding of SDC3 to chemokines, which limit their availability to recruit inflammatory cells18.   62 
Mesenchymal stem cells (MSCs) play a major role in the maintenance and regeneration of adult 63 
tissues subjected to physiological turnover or following injury19. MSCs exert immunomodulatory 64 
functions, including inhibition of T cell proliferation, interference with B cell function and dendritic cell 65 
maturation and promotion of anti-inflammatory macrophage-mediated responses20,21,22. We 66 
previously demonstrated that MSCs reduce inflammation, joint swelling and cartilage destruction in a 67 
murine model of antigen-induced arthritis (AIA)17 and  hypothesise that SDC3 might play an 68 
important role in MSCs biology. A variant of SDC3 is expressed on the surface of human bone 69 
marrow stromal cells where it may be responsible for creating a stromal ‘niche’ for the maintenance 70 
and development of hemopoietic and progenitor cells23. Here, we show a role for SDC3 deletion on 71 
various murine MSC phenotypes, both in vitro and in vivo. MSCs isolated from syndecan-3 null mice 72 
show enhanced adhesion to collagen type I and hyperactivation of the AKT pathway, which are 73 
associated with increased efficacy of MSC treatment in a mouse model of AIA. Thus, our data 74 
further support the idea that pharmacologic targeting of SDC3 might constitute a potentially valuable 75 
therapeutic strategy for inflammatory arthritis. 76 
3 Results 77 
3.1 Characterisation of murine bone marrow MSCs 78 
Wild type and SDC3 murine MSCs were successfully differentiated towards adipogenic, osteogenic 79 
and chondrogenic lineages after 21 days in culture with the relevant differentiation media. The 80 
differentiation potential was similar for both wild type and Sdc3-/- mMSCs (Fig. 1a). A colony-forming 81 
units assay was used to assess the proliferative capacity of the cells being expanded in culture, and 82 
the results showed both genotypes retained high proliferation rate in culture (Fig. 1b). The mean 83 
population doubling time (PDT) value for Sdc3-/- MSCs was lower than that for wild type cells but 84 
was not statistically significant (Fig. 1c). Immunophenotypic analysis indicated similar surface 85 
marker expression pattern for both wild type and Sdc3-/- MSCs. Both sets of cells were negative for 86 
haematopoietic markers CD11b and CD45 and for the endothelial cell markers CD31, and positive 87 
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for the mesenchymal markers CD44 and Sca-1. Expression of the general progenitor cell marker 88 
CD34 and of the vascular progenitor marker CD105 was highly variable in MSCs isolated from both 89 
genotypes, with a general trend of both markers being more commonly expressed in MSCs from 90 
Sdc3-/-mice compared with MSCs from wild type mice (Fig. 1d and e). Flow cytometry showed 91 
similar mean values for cell size (FSC, forward scatter) for both cell types (wild type: 92 
112146.53±6324.64; Sdc3-/-: 102259.3533±3460.25) (Fig. 1f). However, the spread cell surface area 93 
of adherent Sdc3-/- MSCs was considerably lower when compared with wild type (Fig. 1g). Similarly, 94 
wild type MSCs showed significantly higher cellular complexity, measured by side scatter (SSC) 95 
values then the Sdc3-/- MSCs (Fig. 1h).  96 
3.2 Syndecan-3 loss improves adhesion on collagen without affecting MSC 97 
migration  98 
Crosstalk between extracellular matrix (ECM) components and MSCs is essential for tissue 99 
formation and maintenance. Syndecan-3 participates directly in cell adhesion the ECM as a collagen 100 
receptor, and might act as an integrin co-receptor by analogy to its close homolog SDC113,24-27.  101 
Thus, we tested wild type and Sdc3-/- MSC adhesion to various ECM substrates. Without ECM 102 
coating, approximately 65% of wild type and Sdc3-/- cells were attached to tissue culture treated 103 
plates within 1 hour of incubation (Fig. 2a), however, when seeded onto collagen-coated tissue 104 
culture plates, Sdc3-/- MSCs adhered more quickly than wild type MSCs (p=0.014) (Fig. 2b). 105 
Similarly, fibronectin improved Sdc3-/-  MSC adhesion by ~19% compared with wild type MSCs, 106 
although this difference was not statistically significant (Fig. 2c). Interestingly, laminin coating 107 
appeared to yield the opposite effect of collagen and fibronectin coating, although the difference in 108 
adhesion to laminin between wild type and Sdc3-/- MSCs was not statistically significant (Fig. 2d). 109 
 110 
We further analysed the effect of syndecan-3 deletion on cell migration by the scratch and transwell 111 
assays. When cells were cultured in serum-free medium (SFM) or complete expansion medium 112 
(CEM) with either full serum content (FBS and HS, fCEM) or reduced serum content (CEM with 1% 113 
FBS and 1% HS, rCEM) in a scratch assay, wild type MSCs migrated slightly faster than Sdc3-/- 114 
MSCs but differences were not significant (Fig. 2e).  To further investigate a potential role for SDC3 115 
in MSC migration, we tested cell migration towards specific chemoattractants using a transwell 116 
assay. In the absence of chemoattractants, Sdc3-/- MSCs showed a tendency to migrate less than 117 
wild type MSCs, and although serum addition to the lower chamber increased MSC migration in a 118 
dose-dependent manner, the difference in migration between wild type and Sdc3-/- MSCs remained 119 
constant and non-statistically significant (Fig. 2f). Pleiotrophin is a major soluble ligand for SDC3 120 
and acts as a chemoattractant for osteoblasts and neural progenitors in a SDC3-dependent 121 
manner12. When pleiotrophin was added to low serum concentrations in the lower chamber of 122 
transwells it failed to enhance MSC migration (Fig. 2f). All these data together suggest that the slight 123 
migration defect observed in Sdc3-/- MSCs is due to an intrinsic property of Sdc3-/- MSCs rather than 124 
to a role for SDC3 in sensing external chemoattracting cues.  125 
3.3 Syndecan-3 regulates ERK and AKT signalling pathways in MSCs 126 
The results shown so far suggest a role for SDC3 in the regulation of MSC adhesion via one or more 127 
collagen receptors. Typical collagen receptors are integrins, which signal via several kinase-128 
regulated pathways, and some tyrosine kinase receptors28,29. Previous work demonstrated that 129 
Sdc3-/- satellite cell-derived myoblasts had a global increase in phosphorylated-tyrosine (pY), 130 
suggesting SDC3 is involved in regulating numerous signalling pathways simultaneously. Therefore, 131 
we first measured the levels of pY by western blot in wild type and Sdc3-/- MSCs but found no 132 
difference (Fig. 3a and b) and found no differences between the two genotypes.  133 
Common kinase pathways downstream several adhesion complexes are the RAS/ERK pathways and 134 
the PI3K/AKT pathway30. Thus, we investigated changes in phosphorylated AKT and ERK1/2. Here 135 
we found that the levels of pAKTS473 were significantly increased in Sdc3-/- MSCs compared to wild 136 
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprintthis version posted June 12, 2020. ; https://doi.org/10.1101/2020.06.12.148221doi: bioRxiv preprint 
 
4 
type MSCs (Figure 3c). In contrast, the levels of pERK1/2 significantly decreased when SDC3 was 137 
lost from MSCs (Figure 3d), suggesting a role for SDC3 in inhibiting AKT signalling while promoting 138 
ERK1/2 signalling in MSCs adhering to collagen. 139 
3.4 Syndecan-3 loss in MSCs improves arthritic symptoms in AIA 140 
The anti-inflammatory capability of MSCs from wild type and Sdc3-/- mice were tested in the AIA 141 
mouse model of inflammatory arthritis. This model shares many histopathological and clinical 142 
features seen in human RA31.  MSC treatments (wild type and Sdc3-/-) reduced joint swelling as a 143 
measure of joint inflammation compared to serum-free medium control at days 2 (p<0.05) and 3 144 
(p<0.05) post arthritis induction (Fig. 4a). Significant reductions were also recorded in exudates in 145 
the joint cavity and cartilage loss at day 3 following MSC treatment and in overall arthritis index at 146 
day 3 post-arthritis induction (Fig. 4b). At day 7 post-arthritis induction, the histological scores were 147 
reduced but not significantly (Supplementary Fig. 1). There were no significant differences in the 148 
histological parameters between knees treated with MSCs from wild type mice and knees treated 149 
with MSCs from Sdc3-/- mice. 150 
4 Discussion 151 
In this work we describe a role for the transmembrane proteoglycan SDC3 in MSC biology, with a 152 
particular focus on its role as an adhesion molecule and its involvement in MSC-mediated promotion 153 
of cartilage repair in a model of inflammatory arthritis.  154 
Phenotypic characterisation of MSCs isolated from Sdc3-/- mice showed that the overall effect of 155 
SDC3 loss in mice does not produce dramatic effects on MSCs as Sdc3-/- retained multilineage 156 
potential in vitro and similar proliferation rates as wild type MSCs. Immunophenotyping analysis also 157 
revealed similar surface marker expression pattern for both wild type and Sdc3-/- MSCs. However, 158 
endoglin (CD105), a transmembrane glycoprotein that acts as an accessory to the transforming 159 
growth factor β (TGFβ) receptor system32, was more commonly expressed in MSCs from Sdc3-/- 160 
mice compared with MSCs from wild type mice. Endoglin is an MSC marker and it is expressed in 161 
progenitor cells involved in vascular remodelling in animal models of myocardial infarction and 162 
rheumatic diseases33,34. It has been shown that endoglin promotes angiogenesis in cell- and animal-163 
based models of retinal neovascularisation and treatment with anti-CD105 antibody inhibits 164 
neovascularisation in oxygen-induced retinopathy model35. Similarly, it has been shown that SDC3 165 
inhibits angiogenic factor in vitro36 and that regenerating muscles of Sdc3-/- mice show enhanced 166 
angiogenesis15.  Thus, it is possible that the increase in CD105 expression in response to SDC3 167 
loss might be linked to the SDC3-mediated regulation of angiogenesis that has been observed both 168 
in vitro and in vivo. 169 
Obtaining a sufficient number of cells to initiate cell therapy is a limiting factor during therapeutic 170 
applications. Cells must be expanded in vitro prior to in vivo administration and cell adhesion is 171 
necessary for MSC expansion and further therapeutic use37. Our results showed a role for SDC3 in 172 
the regulation of MSC adhesion via one or more collagen receptors. Previous work demonstrated 173 
the cooperation of α2β1 integrin with SDC1 during adhesion to collagen38, and cooperation of α2β1 174 
integrin and α6β4 integrin with syndecans during adhesion to laminin39,40. A recent study has further 175 
confirmed that collagen promotes cell proliferation, cell survival under stress and a stronger cell 176 
adhesion to the cell culture surface37. Since the attachment of MSC to collagen is mostly β1 integrin-177 
mediated41, it is likely that SDC3 regulates MSC adhesion to collagen via β1 integrin. 178 
Cell migration is an essential biological process involved many aspects of health and disease, 179 
including development, tissue regeneration, inflammation, and cancer progression. In this study we 180 
used two in vitro assays to study MSC migration, With the scratch assay, we studied the effects of 181 
cell–matrix and cell–cell interactions on cell migration; with the transwell assay we studied the ability 182 
of cells to directionally respond to chemoattractants42. Our results showed that wild type MSCs 183 
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migrated slightly faster than Sdc3-/- MSCs in both assays, suggesting a role for SDC3 in the 184 
regulation of cell motility. Whether SDC3-mediated regulation of MSC migration is directly linked to 185 
SDC3-mediated regulation of adhesion or via other pathways, remains to be established. In other 186 
cell types SDC3 regulates migration by functioning as a ligand for the soluble factor heparin-binding 187 
growth-associated molecule (HB-GAM) also known as pleiotrophin43,44.  However, pleiotrophin failed 188 
to enhance migration of both wild type and Sdc3-/- MSCs in our transwell assays, suggesting that, at 189 
least under our experimental conditions, SDC3-mediated regulation of MSC migration is not 190 
pleiotrophin-dependent. Moreover, since we observed the same slight difference in migration 191 
between wild type and Sdc3-/- MSCs regardless of the chemoattractant used, we conclude that such 192 
migration defect is due to an intrinsic property of Sdc3-/- MSCs rather than to a role for SDC3 in 193 
sensing external chemoattracting cues. 194 
As discussed above, our data suggest that SDC3 regulates integrin-mediated MSC adhesion to 195 
collagen. Indeed, Sdc3-/- mMSCs cultured on collagen showed a dramatic increase in AKT 196 
phosphorylation, which was accompanied by a decrease in ERK1/2 phosphorylation compared with 197 
wild type controls. The adhesion and signalling phenotypes shown by Sdc3−/− MSCs are mirrored by 198 
the phenotypes reported for loss of 2 and 11 integrin, both collagen I receptors, in human MSCs, 199 
which leads to decreased AKT phosphorylation, MSC adhesion to collagen I and cell spreading45. 200 
Thus, our data strongly suggest a role for SDC3 in MSC adhesion and signalling by regulating 201 
integrin-collagen interaction.  202 
The immunomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) has been 203 
widely studied and this current study has attempted to characterise the role that SDC3 plays in MSC 204 
biology. Deletion of SDC3 led to improvement of clinical scores, leukocyte recruitment and cartilage 205 
damage in a murine model of antigen-induced arthritis17 suggesting that SDC3 contributes to the 206 
clinical manifestation of the disease. In the current work experiments, MSC treatments (wild type 207 
and Sdc3-/-) significantly reduced exudates in the joint cavity and cartilage loss at day 3 following 208 
MSC treatment and the overall arthritis index at day 3 post-arthritis induction. Sdc3-/- MSCs were 209 
more effective than wild type cells at reducing the overall disease severity. SDC3 deletion enhances 210 
the efficacy of MSC treatment in an AIA model of inflammatory arthritis. Our study indicates 211 
important role for SDC3 in MSC biology which requires further investigation. 212 
5 Materials and methods  213 
5.1 Mice 214 
Wild type mice, C57Bl/6 background, for MSC isolation and for the inflammatory arthritis model were 215 
obtained from Envigo, UK and housed in a pathogen-free facility at Liverpool John Moores 216 
University, in accordance with the Animals (Scientific Procedures) Act 1986 and the EU Directive 217 
2010/63/EU, and after local ethical review and approval by the Animal Welfare and Ethical Review 218 
Body. Syndecan-3 null (Sdc3−/−) mice, sharing the same C57Bl/6 background as wild type mice 219 
(Reizes O et al, 2001), were donated by Dr Rauvala, University of Helsinki and housed in a 220 
pathogen-free facility at the University of Liverpool, in accordance with the Animals (Scientific 221 
Procedures) Act 1986 and the EU Directive 2010/63/EU, and after local ethical review and approval 222 
by the Animal Welfare and Ethical Review Body.  223 
5.2 Isolation, expansion, and characterisation of MSCs  224 
MSCs were isolated from bone marrow of wild type (n=6) and Sdc3-/- (n=6) mice using a modified 225 
plastic adherence culture method46. Isolated murine MSCs were cultured in complete expansion 226 
medium (CEM) (Iscove Modified Dulbecco Medium (IMDM) (Gibco, UK) supplemented with 9% 227 
foetal bovine serum (FBS) (Gibco, UK), 9% horse serum (HS) (Gibco, UK) and 1% penicillin-228 
streptomycin (Lonza, UK)) and used between passage 3 and 5. Cells were characterised in terms of 229 
their surface markers through immunophenotyping, growth kinetics by population doubling time 230 
(PDT) assay and colony forming units fibroblast (CFU-F) assay, and trilineage differentiation 231 
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potential (adipogenic, osteogenic and chondrogenic) as previously described17. MSCs were tested 232 
for immunophenotype with the following antibodies: Ly-6A (Sca-1)-PE, CD44-PE, CD11b-PE, CD45-233 
PE, CD105-PE, CD34-FITC and CD31-PE (all from eBioscience) using the FACSCanto II Flow 234 
Cytometer (BD Biosciences) and output data were assessed using Flowing Software 2.5.1 (Perttu 235 
Terho, Cell Imaging Core, Turku Centre for Biotechnology, University of Turku).  236 
5.3 Adhesion assay 237 
For cell adhesion assays, 96-well plates were coated with laminin, fibronectin or collagen type I at 238 
1µg/cm2 (Sigma-Aldrich, UK) overnight at 4°C. After being blocked with BSA, 50 µl of 4x105 cells/ml 239 
were plated to each well. Plates were incubated for 60 min, and non-adherent cells were washed 240 
with PBS, fixed with 4% formaldehyde and labelled with 5 mg/mL crystal violet for 10 min. Unbound 241 
dye was washed away with PBS, and the cells were lysed with 2% SDS before the absorbance at 242 
550 nm was measured on FLUOstar OMEGA microplate reader (BMG Labtech, UK). Non-coated 243 
wells were also seeded and adhesion results were compared between the two cell genotypes. The 244 
percentage of cell attachment was determined relative to a set of standards with known cell 245 
numbers. Morphometric analysis was performed on 4% PFA-fixed, eosin (Sigma-Aldrich, UK)-246 
stained cells. Images were acquired at 4x magnification using Olympus microscope IX-50 and 247 
quantitative data analysis was performed using ImageJ software (NIH, USA). 248 
5.4 Migration: Scratch assay and transwell assay 249 
For cell migration/scratch assays, 24-well plates were coated with 1 µg/cm2 fibronectin overnight at 250 
4°C. 1x105 cells were seeded and incubated at 370C and 5% CO2 until 80% confluence. The cell 251 
monolayer was scratched in a straight line using a p200 pipet tip. Cells were washed with PBS to 252 
remove the debris and smoothen the edges of the scratch and then the culture medium was 253 
replaced with either CEM with full serum content (9% FBS and 9% HS, referred to as fCEM), CEM 254 
with reduced serum content (1% FBS and 1% HS, referred to as rCEM) or serum free medium 255 
(contains all components of CEM but neither FBS or HS, referred to as SFM) to prevent cell 256 
proliferation during migration. A digital image of each scratch was acquired using Olympus 257 
microscope IX-50. Cells were then incubated for 24 hours and all scratches digitally photographed 258 
again in the same location. For both time points ten vertical measurements of the cell layer gap were 259 
acquired, analysed using ImageJ software and the percentage of gap closure was calculated and 260 
compared between the two cell genotypes.  261 
For transwell assays, 200 µl of 5x103 cells in rCEM were seeded on the upper side of transwell 262 
inserts for 24-well plates (membrane 8.0μm pores) (Sarstedt, UK). 500 µl of serum (FBS and HS 263 
(1:1)), rCEM or 10 ng/ml of pleiotrophin in rCEM with 1% serum were added as chemoattractants in 264 
lower compartment. Serum free medium was used as control.  Cells were incubated at 37°C and 5% 265 
CO2 for 15 h, fixed with 4 % paraformaldehyde for 15 min at RT and then washed with PBS. Cells 266 
were stained with DAPI for 10 min protected from light. Cells were counted from 15 random 267 
microscope fields for each sample using Olympus microscope IX-5. Quantitative data analysis was 268 
performed using ImageJ software and results presented as number of migrated cells.  269 
5.5 Western blotting 270 
Cells were lysed in RIPA buffer (R0278, Sigma) supplemented with protease and phosphatase 271 
inhibitor cocktails (Roche), then homogenised by passing the lysate through 21G needle and 272 
syringe. Lysates were clarified by centrifugation and total protein content analysed by BCA assay. 273 
For analysis of SDC3 protein levels, 100 ug of total protein was precipitated with methanol overnight 274 
at -20°C then centrifuged at 13,000 x g to pellet. Pellets were washed once with ice-cold acetone 275 
and resuspended in heparinase buffer (100 mM sodium acetate, 0.1 mM calcium acetate). 276 
Glycosaminoglycan chains were removed using 0.5 mU heparinase III (Ibex, Canada) and 0.5 mU 277 
chondroitinase ABC (Sigma) for 4 hours at 37 °C. Total protein 20 µg (or 40 µg for SDC3 analysis) 278 
was separated by SDS-PAGE and transferred onto nitrocellulose membranes (Hybond, GE 279 
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Healthcare). Primary antibodies used were: p-AKT (1:3000, #4060, CST), AKT (1:3000, #9272, 280 
CST), p-ERK (1:3000, #9101, CST), ERK (1:3000, #9102, CST), p-Tyrosine (1:2000, #8954, CST), 281 
GAPDH (1:8000, G8795, Sigma) and SDC3 (0.14 µg/mL, AF2734, R&D). Secondary HRP-282 
conjugated antibodies were used at 1:10,000 (Santa Cruz). Membranes were visualised using 283 
chemiluminescence (Clarity ECL, Bio-Rad) and imaged using ImageQuant-Las4000 (GE 284 
Healthcare). Band intensity was analysed using ImageJ.   285 
5.6 Antigen-induced arthritis (AIA) 286 
Animal procedures were undertaken in accordance with Home Office project licence P0F90DE46. 287 
AIA was induced in 7- to 8-week-old male C57Bl/6 mice (7–8 weeks) as previously described47. 288 
Briefly, mice were immunised subcutaneously with 1 mg/ml of methylated BSA (mBSA) emulsified 289 
with an equal volume of Freund’s complete adjuvant and injected intraperitoneally with 100 ml heat-290 
inactivated Bordetella pertussis toxin, the subsequent immune response was boosted 1 week later. 291 
Then 3 weeks after the initial immunisation, AIA was induced by intra-articular injection of 10 mg/ml 292 
mBSA into the right knee joint and PBS into the left knee joint to serve as a control. Animals were 293 
inspected daily for arthritis development by measuring knee joint diameters using a digital 294 
micrometer (Kroeplin GmbH). The difference in joint diameter between the arthritic (right) and non-295 
arthritic control (left) in each animal gave a quantitate measure of swelling (in mm).  296 
5.7 Intra-articular injection of MSC  297 
After one day post arthritis induction, 10 µl of SFM, containing 5x105 wild type or Sdc3−/− MSCs were 298 
injected intra-articularly (0.5 mL monoject (29 G) insulin syringe, BD Micro-Fine, Franklyn Lakes, 299 
USA) through the patellar ligament into the right knee joint. Control animals were injected with SFM.  300 
Joint diameters were measured at 1, 2, 3, 5 and 7 days post injection. All measures were taken to 301 
reduce animal numbers (n = 4 per time point). 302 
5.8 Arthritis index  303 
Animals were sacrificed for histological analysis at days 3 and 7. Joints were fixed in 10% neutral 304 
buffered formal saline and processed as described previously48. H&E sections were scored for 305 
hyperplasia of the synovial intima (0 = normal to 3 = severe), cellular exudate (0 = normal to 3 = 306 
severe) and synovial infiltrate (0 = normal to 5 = severe); and Toluidine Blue stained sections for 307 
cartilage loss (0 = normal to 3 = severe) by two independent observers blinded to experimental 308 
groups 47. Scores were summated, producing a mean arthritis index. 309 
5.9 Statistical analysis 310 
Statistical analysis was carried out on GraphPad Prism 5.0. A one-way ANOVA followed by Tukey 311 
post hoc test was used for multiple comparisons and a two-tailed Student t test for comparisons of 312 
two variables.  A p-value < 0.05 was considered significant. 313 
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11 Figure legends 471 
Figure 1. Characterisation of murine bone marrow MSCs. (a) Wild type and Sdc3-/- MSCs show a 472 
similar trilineage differentiation potential in vitro. Yellow scale bar represents 200 µm; black scale bar 473 
represents 500 µm. The proliferative capability of MSCs were measured by (b) fibroblast colony-474 
forming units and (c) average population doubling time (PDT). Dot plots displaying the percentage of 475 
cells expressing CD34 (d) or CD105 (e) as measured by flow cytometry. (f) The geometric mean of 476 
cell size was determined by forward scatter. (g) The morphometry, or cell spread, of cells were 477 
analysed using ImageJ. (h) The internal complexity of cells was measured by side scatter and the 478 
geometric means are shown. MSCs were isolated from wild type (n=6) and Sdc3-/- (n=6) mice. Data 479 
presented as mean ± standard deviation unless otherwise stated; * = p< 0.05; ** = p< 0.01.  480 
Figure 2. Adhesion to collagen is increased in Sdc3-/- MSCs. MSCs were isolated from wild type 481 
(n=6) and Sdc3-/- (n=6) mice and seeded onto several different substrates in complete expansion 482 
medium (CEM). After 60 min the average percentage of wild type (WT) and Sdc3-/- MSCs adhered to 483 
each substrate was calculated: (a) Non-coated, (b) Collagen type I, (c) Fibronectin and (d) Laminin. 484 
(e) A scratch assay was performed on MSCs cultured in serum free medium (SFM), reduced serum 485 
content medium (rCEM) or full serum content medium (fCEM) and the average percentage of gap 486 
closure is shown. (f) Cell migration towards specific chemoattractants was measured using a transwell 487 
assay. The number of migrated cells was calculated after 15 h of incubation to each chemoattractant. 488 
PTN, pleiotrophin. Data presented as mean ± standard deviation; * P< 0.05. 489 
Figure 3.  Loss of SCD3 in MSCs causes increased ATK phosphorylation and a reduction in 490 
ERK phosphorylation. MSCs were isolated from wild type (n=6) and Sdc3-/- (n=6) mice, cultured in 491 
full growth medium, and lysed ready for western blotting. (a) representative images of blots used for 492 
quantification. SDC3 knockout was confirmed for Sdc3-/- MSCs in each sample (b) Total 493 
phosphorylated tyrosine normalised to GAPDH. (c) Phosphorylated AKTSer473 was normalised to total 494 
AKT. (D) Phosphorylated ERKThr202/Tyr204 was normalised to total ERK. Quantification was performed 495 
using ImageJ. Data displayed as mean ± standard deviation; * = p< 0.05; ** = p< 0.01. 496 
Figure 4.  Effects of intra-articular injections of MSCs in AIA. (a) Knee diameter (mm) was used 497 
as an index of swelling (joint inflammation) and measured at days 1,2,3 and 7 post arthritis induction. 498 
Significant reductions are seen following Sdc3-/- MSCs and Sdc3+/+ MSCs injection in AIA mice. Data 499 
are means ± standard error of the mean (SEM) for right knee after subtraction of left knee control. * 500 
p<0.05 comparing Sdc3-/- MSCs and control mice at the time points indicated; # p<0.05 and ## p<0.01 501 
comparing Sdc3+/+ MSCs and control mice at the time points indicated. (b) The histological scoring for 502 
3 days post arthritis induction. The arthritis index is the sum of all observations. Data are means ± 503 
SEM, n=4 mice in each group; *p<0.05 and ***p<0.001. 504 
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